Mi Mu

3.1k total citations · 2 hit papers
10 papers, 2.0k citations indexed

About

Mi Mu is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Surgery. According to data from OpenAlex, Mi Mu has authored 10 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Infectious Diseases and 2 papers in Surgery. Recurrent topics in Mi Mu's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), COVID-19 Clinical Research Studies (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Mi Mu is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), COVID-19 Clinical Research Studies (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Mi Mu collaborates with scholars based in China, United States and United Kingdom. Mi Mu's co-authors include Yingzhen Du, Tianzhi Li, Guogang Xu, Runsheng Wang, Qinyong Hu, Lei Tu, Chao Hu, Pengcheng Yang, Jun‐Hong Yan and Lei Pan and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Hypertension and Frontiers in Immunology.

In The Last Decade

Mi Mu

10 papers receiving 1.9k citations

Hit Papers

Clinical Characteristics of COVID-19 Patients With Digest... 2020 2026 2022 2024 2020 2020 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mi Mu China 8 1.4k 762 339 228 205 10 2.0k
Pengcheng Yang China 6 1.5k 1.0× 772 1.0× 343 1.0× 190 0.8× 197 1.0× 9 2.0k
Yingzhen Du China 12 1.5k 1.1× 816 1.1× 354 1.0× 241 1.1× 297 1.4× 25 2.3k
Qinyong Hu China 14 1.6k 1.1× 844 1.1× 502 1.5× 279 1.2× 237 1.2× 35 2.5k
Hongliu Cai China 16 1.6k 1.1× 774 1.0× 416 1.2× 202 0.9× 318 1.6× 51 2.7k
Huaying Wang China 7 1.1k 0.8× 599 0.8× 285 0.8× 223 1.0× 186 0.9× 19 1.8k
Liping Deng China 13 1.6k 1.1× 924 1.2× 375 1.1× 155 0.7× 385 1.9× 50 2.2k
Dilek Azkur Türkiye 15 1.2k 0.9× 574 0.8× 240 0.7× 192 0.8× 216 1.1× 32 2.1k
Pingzheng Mo China 13 1.8k 1.3× 981 1.3× 376 1.1× 117 0.5× 300 1.5× 25 2.3k
Mingqi Luo China 9 1.4k 1.0× 791 1.0× 462 1.4× 114 0.5× 287 1.4× 26 1.8k

Countries citing papers authored by Mi Mu

Since Specialization
Citations

This map shows the geographic impact of Mi Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mi Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mi Mu more than expected).

Fields of papers citing papers by Mi Mu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mi Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mi Mu. The network helps show where Mi Mu may publish in the future.

Co-authorship network of co-authors of Mi Mu

This figure shows the co-authorship network connecting the top 25 collaborators of Mi Mu. A scholar is included among the top collaborators of Mi Mu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mi Mu. Mi Mu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Wang, Lei, Mi Mu, Yu Guo, et al.. (2024). PD-1/PD-L1 Provides Protective Role in Hypoxia-Induced Pulmonary Vascular Remodeling. Hypertension. 81(8). 1822–1836. 7 indexed citations
2.
Gong, Jiuyu, Fangfang Tian, Qin Wang, et al.. (2022). Case report: Rare epithelioid hemangioendothelioma occurs in both main bronchus and lung. Frontiers in Medicine. 9. 1066870–1066870. 1 indexed citations
4.
Yang, Yi, Jing Jing Wang, Xin Zhang, et al.. (2021). Role of the IL-33/ST2 axis in cigarette smoke-induced airways remodelling in chronic obstructive pulmonary disease. Thorax. 76(8). 750–762. 17 indexed citations
5.
Hu, Lin, Qin Wang, Fangfang Tian, et al.. (2021). Drug-Eluting Beads Bronchial Arterial Chemoembolization in Treating Relapsed/Refractory Small Cell Lung Cancer Patients: Results from a Pilot Study. Cancer Management and Research. Volume 13. 6239–6248. 12 indexed citations
6.
Gao, Wei, Jiuyu Gong, Mi Mu, et al.. (2021). The Pathogenesis of Eosinophilic Asthma: A Positive Feedback Mechanism That Promotes Th2 Immune Response via Filaggrin Deficiency. Frontiers in Immunology. 12. 672312–672312. 14 indexed citations
7.
Pan, Lei, Runsheng Wang, Na Yu, et al.. (2021). Clinical characteristics of re-hospitalized COVID-19 patients with recurrent positive SARS-CoV-2 RNA: a retrospective study. European Journal of Clinical Microbiology & Infectious Diseases. 40(6). 1245–1252. 6 indexed citations
8.
Du, Yingzhen, Lei Tu, Pingjun Zhu, et al.. (2020). Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study. American Journal of Respiratory and Critical Care Medicine. 201(11). 1372–1379. 642 indexed citations breakdown →
9.
Du, Yingzhen, Pingjun Zhu, Xi Wang, et al.. (2020). Pirfenidone alleviates lipopolysaccharide-induced lung injury by accentuating BAP31 regulation of ER stress and mitochondrial injury. Journal of Autoimmunity. 112. 102464–102464. 33 indexed citations
10.
Pan, Lei, Mi Mu, Pengcheng Yang, et al.. (2020). Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study. The American Journal of Gastroenterology. 115(5). 766–773. 1234 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026